BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38175754)

  • 21. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis.
    Liu YF; Zhuang KH; Chen B; Li PW; Zhou X; Jiang H; Zhong LM; Liu FB
    Arthritis Res Ther; 2018 Aug; 20(1):168. PubMed ID: 30075733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Noncoding RNA RUNXOR Promotes Myeloid-Derived Suppressor Cell Expansion and Functions via Enhancing Immunosuppressive Molecule Expressions during Latent HIV Infection.
    Zhang J; Thakuri BKC; Zhao J; Nguyen LN; Nguyen LNT; Khanal S; Cao D; Dang X; Schank M; Lu Z; Wu XY; Morrison ZD; El Gazzar M; Jiang Y; Ning S; Wang L; Moorman JP; Yao ZQ
    J Immunol; 2021 May; 206(9):2052-2060. PubMed ID: 33820854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.
    Wang L; Hu D; Xie B; Xie L
    Invest New Drugs; 2022 Jun; 40(3):506-518. PubMed ID: 35089465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cells.
    Eruslanov E; Daurkin I; Ortiz J; Vieweg J; Kusmartsev S
    J Leukoc Biol; 2010 Nov; 88(5):839-48. PubMed ID: 20587738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation.
    Bian Z; Abdelaal AM; Shi L; Liang H; Xiong L; Kidder K; Venkataramani M; Culpepper C; Zen K; Liu Y
    Eur J Immunol; 2018 Jun; 48(6):1046-1058. PubMed ID: 29488625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.
    Neo SY; Tong L; Chong J; Liu Y; Jing X; Oliveira MMS; Chen Y; Chen Z; Lee K; Burduli N; Chen X; Gao J; Ma R; Lim JP; Huo J; Xu S; Alici E; Wickström SL; Haglund F; Hartman J; Wagner AK; Cao Y; Kiessling R; Lam KP; Westerberg LS; Lundqvist A
    Sci Transl Med; 2024 May; 16(747):eadi2952. PubMed ID: 38748775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.
    Sahraei M; Bose M; Sanders JA; De C; DasRoy L; Nath S; Brouwer CR; Mukherjee P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloid-Derived Suppressor Cell-Derived Arginase-1 Oppositely Modulates IL-17A and IL-17F Through the ESR/STAT3 Pathway During Colitis in Mice.
    Ma Z; Zhen Y; Hu C; Yi H
    Front Immunol; 2020; 11():687. PubMed ID: 32391010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. M-MDSC
    Aintablian A; Strozniak S; Heuer M; Lutz MB
    Front Immunol; 2023; 14():1130600. PubMed ID: 37275910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
    Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
    Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of myeloid-derived suppressor cell differentiation ex vivo.
    Blanco E; Escors D; Kochan G
    Methods Cell Biol; 2024; 184():85-96. PubMed ID: 38555160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.
    Trovato R; Fiore A; Sartori S; Canè S; Giugno R; Cascione L; Paiella S; Salvia R; De Sanctis F; Poffe O; Anselmi C; Hofer F; Sartoris S; Piro G; Carbone C; Corbo V; Lawlor R; Solito S; Pinton L; Mandruzzato S; Bassi C; Scarpa A; Bronte V; Ugel S
    J Immunother Cancer; 2019 Sep; 7(1):255. PubMed ID: 31533831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyamine Blocking Therapy Decreases Survival of Tumor-Infiltrating Immunosuppressive Myeloid Cells and Enhances the Antitumor Efficacy of PD-1 Blockade.
    Alexander ET; Mariner K; Donnelly J; Phanstiel O; Gilmour SK
    Mol Cancer Ther; 2020 Oct; 19(10):2012-2022. PubMed ID: 32747421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator.
    Oliver L; Alvarez R; Diaz R; Valdés A; Colligan SH; Nemeth MJ; Twum DYF; Fernández A; Fernández-Medina O; Carlson LM; Yu H; Eng KH; Hensen ML; Rábade-Chediak ML; Fernández LE; Lee KP; Perez L; Muhitch JB; Mesa C; Abrams SI
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36150744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy.
    Draghiciu O; Lubbers J; Nijman HW; Daemen T
    Oncoimmunology; 2015 Jan; 4(1):e954829. PubMed ID: 25949858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell Immunity.
    Cimen Bozkus C; Elzey BD; Crist SA; Ellies LG; Ratliff TL
    J Immunol; 2015 Dec; 195(11):5237-50. PubMed ID: 26491198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating STAT3.
    Ma M; Huang W; Kong D
    Int Immunopharmacol; 2018 Jun; 59():148-156. PubMed ID: 29655056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fully functional monocytic MDSC generation from the murine HoxB8 cell line.
    Alattar H; Xu H; Zenke M; Lutz MB
    Eur J Immunol; 2023 Sep; 53(9):e2350466. PubMed ID: 37367431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.